Cargando…
The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public Institution(s). Main funding source(s): PSIDER (ZOn-MW) PREDICT2 (Hartstichting) BACKGROUND: The PLN p.Arg14del risk model is a mutation-specific risk model developed to predict individual malignant ventricular arrhythmia (VA) risk to inform...
Autores principales: | Van Der Heide, M Y C, Verstraelen, T E, Van Lint, F H M, Bosman, L P, De Brouwer, R, Proost, V M, Germans, T, Dickhoff, C, Schoonderwoerd, B A, Houweling, A C, Gimeno-Blanes, J R, De Boer, R A, Cox, M G P J, Van Tintelen, P, Wilde, A A M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398618/ http://dx.doi.org/10.1093/europace/euad122.344 |
Ejemplares similares
-
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction
por: Verstraelen, Tom E, et al.
Publicado: (2021) -
Cardiovascular rehabilitation with a WCD
por: Rohrer, U, et al.
Publicado: (2023) -
Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023) -
QRS complex and T wave planarity for the prediction of death and appropriate shocks in recipients of prophylactic implantable defibrillators
por: Novotny, T, et al.
Publicado: (2023) -
Utility of cardiac magnetic resonance in assessing arrhythmic risk in patients with non ischemic cardiomyopathy undergoing biventricular pacing
por: Sayed, M, et al.
Publicado: (2023)